Knott David M Jr
Source: SEC Form 13F · as of Mar 2026Knott David M Jr holds 23 biotech & pharma companies tracked by BioSniper, totaling $55.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
23
Total value held
$55.9M
BioSniper AIPage context preserved
Prepared research question
What matters most for BridgeBio Pharma, Inc. (BBIO)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| BBIOBridgeBio Pharma, Inc. | 90,000 | $6.7M |
| PTGXProtagonist Therapeutics, Inc | 63,000 | $6.6M |
| XERSXeris Biopharma Holdings, Inc. | 1,060,000 | $6.1M |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 1,600,000 | $5.6M |
| TVTXTravere Therapeutics, Inc. | 140,633 | $4.2M |
| COGTCogent Biosciences, Inc. | 104,000 | $4.0M |
| VRDNViridian Therapeutics, Inc.\DE | 181,000 | $3.5M |
| AGIOAGIOS PHARMACEUTICALS, INC. | 93,058 | $3.1M |
| RLMDRELMADA THERAPEUTICS, INC. | 439,300 | $3.1M |
| TGTXTG THERAPEUTICS, INC. | 90,001 | $3.0M |
| RCUSArcus Biosciences, Inc. | 81,241 | $1.8M |
| CYTKCYTOKINETICS INC | 23,644 | $1.6M |
| CNTACentessa Pharmaceuticals plc | 39,000 | $1.5M |
| ARDXARDELYX, INC. | 207,000 | $1.2M |
| RZLTRezolute, Inc. | 370,000 | $1.1M |
| ADMAADMA BIOLOGICS, INC. | 60,200 | $542K |
| PTHSPelthos Therapeutics Inc. | 21,073 | $443K |
| KURAKura Oncology, Inc. | 52,767 | $429K |
| CGEMCullinan Therapeutics, Inc. | 24,200 | $344K |
| SLDBSolid Biosciences Inc. | 47,143 | $339K |
| LENZLENZ Therapeutics, Inc. | 33,732 | $309K |
| JSPRJasper Therapeutics Inc. | 160,789 | $141K |
| IVVDInvivyd, Inc. | 100,000 | $130K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.